Policy | May 09, 2023
Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
Chief Imam of All India Imam Organization, Dr. Imam Umer Ahmed Ilyas, evinces keen interest in the eradication of Thalassemia & Sickle Cell Disease
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
The company has launched its new range of 25 allopathy ophthalmic products including GUERIMOD, GUERIPRED, BIMATO MST etc. for curing various diseases related to eyes
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
Subscribe To Our Newsletter & Stay Updated
